The board pack from digital and growth: the two pages that get read
The first board pack I contributed to had eleven pages from digital. Traffic, sessions, followers, campaign reach, a heat map of the website, a chatbot containment number and a slide of screenshots. It was not read. A director asked one question — “how many patients did this produce?” — and the answer was on none of the eleven pages.
The pack that finally got read was two pages, and most of the second page was a table. It took three quarters to get there, and the hardest part was not deciding what to put in. It was deciding what to leave out, and then holding the line when every function wanted its number back.
This is about what a hospital board should see from digital and growth each quarter, how to structure it, which handful of metrics survive, how to show risk without either hiding it or performing it, and the difference between a marketing report and a board paper. They are different documents for different readers, and the confusion between them is why most growth sections of a board pack are skipped.
Who the reader is
A hospital group board is a mixture of the promoter family, an independent director or two with a finance or governance background, sometimes an investor nominee, sometimes a senior clinician. They see the group four times a year for a day. They have the CFO’s pack, the CEO’s report, the medical quality report and the audit committee minutes in front of them, and yours is somewhere after the eighth tab.
They are not interested in marketing. They are interested in three questions. Is demand for the group growing, and is that demand being converted into patients efficiently? Is the money being spent on growth producing a return that can be defended? And is there anything on the demand side that could hurt the group before the next meeting — a regulatory exposure, a data risk, a reputational problem building somewhere they cannot see?
Everything in the pack should answer one of those three. Anything that does not is a marketing report that has wandered into the wrong room.
The structure that gets read
Two pages. A third only if a decision is being asked for.
Page one is narrative: five or six short paragraphs. What happened to demand this quarter and why. What happened to conversion and cost. The one thing that went wrong and what is being done. The one risk the board should know about. The one decision, if any, the board is being asked to make. Written in plain sentences a director with no digital background can read in four minutes.
Page two is the table: the handful of metrics, this quarter against last quarter and the same quarter last year, by unit where it matters, with a short note against any number that moved unexpectedly. No charts unless the chart makes a trend clearer than the number does. No colour coding that pretends to be analysis.
Page three, when it exists, is the decision paper — a capital request, a new format, a vendor commitment above the CEO’s authority — written to the board’s own template with the demand case, the P&L consequence, the risk and the recommendation.
That is all. The detailed marketing pack still exists. It goes to the executive committee monthly and it is available to any director who asks. It does not go in the board book.
The metrics that survive
The hardest edit. Every line below was fought over, and every line that was removed had a champion.
The table has a headline row and a supporting block. The headline row is what growth is accountable for, and it should be very short: what a new patient costs the group to acquire, how much demand the group generated and could not serve, and what a new patient is worth after a year. Three numbers, group-level, against last quarter and the same quarter a year ago. A director who reads only that row knows whether the engine is running, whether it is getting dearer, and whether what it produces is worth keeping.
The supporting block explains the headline when it moves, and nothing else:
- Enquiries and enquiry-to-appointment conversion, by unit. When the cost line moves, this is usually why.
- Share of demand captured — the group’s share of search in its catchments, by unit, against the nearest competitor where the data supports it. The closest thing to market share the demand side can give a board, and boards understand market share.
- Contact centre answer rate and booking rate. Unanswered calls are the unserved demand line in human form.
- Review rating and velocity by unit, because it is the one demand number directors already look at on their own phones.
- Growth spend against budget, reconciled to the CFO’s number and shown next to it.
Repeat and retention goes in only once the CRM data is trustworthy enough to survive a restatement. Before that, leave it out and say so. A board that sees the same table for eight quarters learns to read it, and starts asking better questions than “what is a session”.
What to leave out
Traffic, sessions, page views, followers, reach, impressions, engagement rate, bounce rate, app downloads, chatbot containment, email open rates, campaign-level results, agency performance, creative examples, screenshots of anything. All of these are real and some of them matter operationally. None of them belongs in front of a board, because none of them answers the three questions, and every one of them invites a director to ask a question you will spend ten minutes answering while the CFO watches the clock.
Leave out attribution debates. A board does not want to know that the model is last-touch or that organic and paid overlap. It wants a number it can trust and a note that says how it was built. If the number cannot be trusted, leave it out and say why.
Leave out the AI slide. Every board wants to hear about AI, and the temptation is to give them a page on the chatbot, the voice bot, the content programme. Do not. If AI is producing a result, it is inside the table — the contact centre answer rate improved because the voice bot took first response; the cost per patient fell because search presence improved. Say that in the narrative in one sentence. A separate AI slide is a marketing report.
And leave out anything that claims a result you cannot defend to the CFO the day before. Every number in the pack should have been seen by finance and reconciled with theirs. A board that catches one discrepancy between your patient count and the CFO’s will discount everything you present for a year.
Showing risk honestly
This is where most growth papers fail, in one of two directions. Either the risk section is a single line saying “no material risks identified”, which no experienced director believes, or it is a list of everything that could conceivably go wrong, which is a way of hiding the one that actually might.
The board wants the risk you are actually worried about, stated plainly, with what you are doing about it and what you need from them if anything. In a hospital group’s demand engine, the real ones tend to be:
- Data and consent. The CRM holds patient data across units; the consent framework has gaps; a regulatory change is coming. Say what the exposure is and what the remediation costs.
- Platform dependency. A large share of enquiries arrives through an aggregator or a single search platform whose terms changed. Say how concentrated the demand is and what the group is doing to reduce it.
- Reputational. A unit’s review profile is deteriorating, a specific incident is being amplified, or a departed consultant is taking a visible share of demand with him. Say it before a director reads it on his phone.
- Regulatory in advertising. The rules on what a hospital may claim, name or promote in India are specific and enforced unevenly. A campaign or a piece of AI-generated content that crosses a line is a group problem, not a marketing one.
- Execution. A platform migration, a contact centre transition or a CRM integration that is late and will affect the numbers next quarter. Say so this quarter.
One or two of these, each quarter, with the honest status. A board that hears about a problem from the growth function before it becomes visible learns to trust the function. A board that hears about it afterwards learns the opposite, and does not forget.
The difference between a marketing report and a board paper
A marketing report describes activity. A board paper describes consequence.
A marketing report says what was done: campaigns run, content published, leads generated, channels optimised. Its reader is the person who runs marketing and the executive who manages her. A board paper says what happened to the group as a result — demand, patients, cost, margin, risk — and what the board should decide or know. Its reader has never run a campaign and never will.
A marketing report is written to show the function is busy and competent. A board paper is written to be trusted, which means it includes the quarter that went badly, in the same format and with the same candour as the quarter that went well. The first time a growth paper reports a poor quarter clearly, with the reason and the fix, is the quarter the board starts reading it.
A marketing report uses the vocabulary of the trade. A board paper uses the vocabulary of the P&L. Not “organic search grew” but “the share of new patients who found us without paid media rose, which is why cost per patient fell”. Not “CRM adoption improved” but “we can now see repeat visits reliably for six units, and here is what they show”.
And a marketing report is defended by the marketer. A board paper is defended by the CEO, because it is the CEO who presents it, or sits next to the person who does. Write it so that the CEO can defend it without you in the room. If a paragraph needs you to explain it, rewrite it.
Getting the CFO’s signature before the board’s attention
The single practice that changed the reception of the growth paper was pre-clearing it with finance. Every number reconciled. Every cost against the ledger. Every patient count against the registration system. The CFO reads the narrative and the table a week before the board book closes, and her questions are answered before a director asks them.
This is slower and it is occasionally humbling — the CFO will find things — but it means that when a director turns to the CFO and asks whether the growth numbers are right, the answer is yes. That answer is worth more than anything on the page.
If you’re building this for next quarter
- Ask the company secretary for last year’s board books and read what the board actually asked about in the growth section. That is your reader.
- Pick the headline row and the supporting block and agree them with the CFO and the CEO before you build anything. Once agreed, do not change them for a year.
- Write page one as five paragraphs for a director with no digital background. Test it on one.
- Build the table with finance so that every number reconciles to theirs, and note the method for any that cannot.
- Write the risk paragraph first, not last. If you cannot name a risk, you have not looked.
- Move everything else to the monthly executive committee pack and tell the board it exists.
- Get the CFO’s sign-off a week before the book closes, every quarter, without exception.
The board does not need to understand digital. It needs to trust that someone does, and that the person can tell them the truth in two pages.
If they read it, you got it right. If they ask what a session is, you did not.
Questions people ask
Two pages. Page one is five or six short paragraphs a director with no digital background can read in four minutes: what happened to demand and why, what happened to conversion and cost, the one thing that went wrong, the one risk, and the one decision being asked for. Page two is a table of a handful of metrics against last quarter and the same quarter last year. A third page exists only when a decision is being sought. Everything else goes to the executive committee.
Is demand for the group growing, and is it being converted into patients efficiently? Is the money spent on growth producing a return that can be defended? And is there anything on the demand side that could hurt the group before the next meeting — a regulatory exposure, a data risk, a reputational problem building somewhere they cannot see? Every line in the pack should answer one of those. Anything that does not is a marketing report that has wandered into the wrong room.
Three, at group level: what a new patient costs the group to acquire, how much demand the group generated and could not serve, and what a new patient is worth after a year. A director who reads only that row knows whether the engine is running, whether it is getting dearer, and whether what it produces is worth keeping. The supporting block — enquiry conversion by unit, share of search, contact centre answer rate, review velocity, spend against budget — exists only to explain the headline when it moves.
Traffic, sessions, page views, followers, reach, impressions, engagement, bounce rate, app downloads, chatbot containment, email open rates, campaign results, agency performance, creative and screenshots of anything. All are real and some matter operationally. None answers the board’s three questions, and every one invites a ten-minute question while the CFO watches the clock. Leave out attribution debates too — the board wants a number it can trust and a note on how it was built. And leave out any number finance has not seen.
A marketing report describes activity; a board paper describes consequence. The report says what was done — campaigns run, leads generated — and is written to show the function is busy. The board paper says what happened to the group — demand, patients, cost, margin, risk — and is written to be trusted, which means it includes the bad quarter in the same format as the good one. It uses the vocabulary of the P&L, not the trade, and it is defended by the CEO, not the marketer.
Name the one or two risks you are actually worried about, plainly, with what you are doing and what you need from the board. Not “no material risks identified”, which no experienced director believes, and not a list of everything conceivable, which hides the real one. In a hospital demand engine the real ones tend to be data and consent, dependence on a single platform, a unit’s deteriorating reviews, advertising regulation, and a late migration that will affect next quarter’s numbers. Write the risk paragraph first.
Because a board that catches one discrepancy between your patient count and the CFO’s will discount everything you present for a year. Every number reconciled, every cost against the ledger, every patient count against the registration system, a week before the board book closes. The CFO will find things, and it is occasionally humbling. But when a director turns to the CFO and asks whether the growth numbers are right, the answer is yes, and that answer is worth more than anything on the page.
No. Every board wants to hear about AI and the temptation is a page on the chatbot, the voice bot and the content programme. If AI is producing a result it is already inside the table — the contact centre answer rate improved because the voice bot took first response, cost per patient fell because search presence improved. Say that in one sentence of the narrative. A separate AI slide is a marketing report, and it invites the one question you will spend ten minutes answering.
About three quarters, in my experience, and the hard part is not deciding what to put in but holding the line when every function wants its number back. Pick the headline row and supporting block with the CFO and CEO before building anything, and do not change them for a year. A board that sees the same table for eight quarters learns to read it and starts asking better questions. The first pack that reports a bad quarter clearly is the one the board starts reading.
The CEO, or the CEO sits next to the person who does. Write it so the CEO can defend it without you in the room; if a paragraph needs you to explain it, rewrite it. The growth leader’s job is to have pre-cleared every number with finance and to have tested page one on a director with no digital background. Ask the company secretary for last year’s board books and read what the board actually asked about in the growth section. That is your reader.
That the CRM holds patient data across units, that the consent framework has gaps, and that a regulatory change is coming — stated with the exposure and the remediation cost. Also platform dependency: a large share of enquiries arriving through one aggregator or search platform whose terms can change. These are group risks, not marketing ones. A board that hears about them from the growth function before they become visible learns to trust the function. One that hears afterwards learns the opposite and does not forget.
The board reads it, and the questions change. If a director asks what a session is, you got it wrong. If directors start asking why unserved demand rose in one unit, or whether the acquisition cost trend justifies a capital request, the pack is doing its job. The other test is trust: when a director asks the CFO whether the growth numbers are right and the CFO says yes without hesitation. That takes reconciled numbers every quarter, without exception.
The same structure, with less in it. Two pages still, three headline numbers still, one honest risk still. The supporting block loses the by-unit comparison but gains sharper local detail: share of search in one catchment, one contact centre’s answer rate, one review profile. The discipline of reconciling with finance matters more, not less, because a single hospital’s board is often the promoter family, who know the revenue line to the rupee and will notice a patient count that does not match.
Ask how the patient count reconciles to the registration system and whether the CFO has seen it. Ask how the acquisition cost was built — if the answer involves an attribution model, ask what share of patients would have come anyway. Ask what demand went unserved, because a good cost number with rising unserved demand means the engine is producing patients the hospital cannot see. And ask which risk the function chose not to write about this quarter. An honest growth leader will have one ready.
